Compounds with PTH activity

Details Compounds with PTH activity Compounds with PTH activity

1993-10-25

1998-09-29

Kemmerer, Elizabeth C.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530 4, 530399, 530402, A61K 3829, C07K 1113

Patent

active

058146032

ABSTRACT:
PTH analogs comprising an amino acid sequence that is: SVSEIQLLHNX.sub.1 X.sub.2 X.sub.3 HX.sub.4 X.sub.3 X.sub.3 X.sub.3 X.sub.5 RVX.sub.5 WLR X.sub.4 X.sub.4 LX.sub.3 X.sub.3 VX.sub.1 X.sub.3 X.sub.3 X (SEQ ID NO:10) wherein X.sub.1 is a neutral or positively charged amino acid, X.sub.2 is a neutral amino acid, X.sub.3 is a neutral, positively charged, or negatively charged amino acid, X.sub.4 is a positively charged amino acid, X.sub.5 is a positively charged or negatively charged amino acid, and X is selected from the group consisting of Hol, Ho, a homoserine amide, or the sequence of amino acids comprising residues 35-84 of PTH, have enhanced activity and increased serum half-life as compared with human PTH. The PTH analogs can be produced as fusion proteins in high yields in E. coli host cells; the fusion proteins can be subsequently cleaved to produce the PTH analog.

REFERENCES:
patent: 3886132 (1975-05-01), Brewer et al.
patent: 4423037 (1983-12-01), Rosenblatt et al.
patent: 4632780 (1986-12-01), Seidah et al.
patent: 4656250 (1987-04-01), Morita et al.
patent: 4771124 (1988-09-01), Rosenblatt et al.
patent: 4968669 (1990-11-01), Rosenblatt et al.
patent: 5001223 (1991-03-01), Rosenblatt et al.
patent: 5010010 (1991-04-01), Gautvik et al.
patent: 5171670 (1992-12-01), Kronenberg et al.
patent: 5455329 (1995-10-01), Wingender et al.
patent: 5457047 (1995-10-01), Wingender et al.
patent: 5589452 (1996-12-01), Krstenansky et al.
patent: 5599792 (1997-02-01), Kronis et al.
patent: 5693616 (1997-12-01), Krstenansky et al.
patent: 5695955 (1997-12-01), Krstenansky et al.
Potts et al. Parathyroid hormone: chemistry, biosynthesis, and mode of action. Advances in Protein Chemistry. vol. 35, pp. 323-396, 1982.
Tashijian et al., 1964, Biochemistry 3: 1175-1182 Alkylation and Oxidation of Methionine in Bovine parathyroid Hormone: Effects on Hormonal Activity and Antigenicity.
Potts et al., 1971, Proc. Natl. Acad. Sci. USA 68: 63-67 Synthesis of a Biologically Active N-Terminal Tetratriacontapeptide of Parathyroid Hormone.
Treager et al., 1973, Endocrinology 93 (6): 1349-1353 Bovine Parathyroid Hormone: Minimum Chain Length of Synthetic Peptide Required for Biological Activity.
Goltzmann et al., 1975, J. Biol. Chem. 250:3199-3203 Analysis of the Requirements for Parathyroid Hormone Action in Renal Membranes with the use of Inhibiting Analogues.
Rosenblatt et al., 1976, J. Biol. Chem. 251: 159-164 Chemical and Biological Properties of Synthetic, Sulfur-free Analogues of Parathyroid Hormone.
Goltzmann et al., 1978, Endocrinology 103: 1352-1360 Influence of Guanyl Nucleotides on Parathyroid Hormone-Stimulated Adenylyl Cyclase Activity in Renal Cortical Membranes.
Segre et al., 1979, J. Biol. Chem. 254:6980-6986 Characterization of Parathyroid Hormone Receptors in Canine Renal Cortical Plasma Membranes Using a Radiodinated Sulfur-free Hormone Analogue.
Rosenblatt, 1981, Pathobiology Annual 11:53-86 Parathyroid Hormone: Chemistry and Structure-Activity Relations.
Frelinger and Zull, 1984, J. Biol. Chem. 259: 5507-5513 Oxidized Forms of Parathyroid Hormone with Biological Activity.
Frelinger and Zull, 1986, Arch. Biochem. Biophys. 244:641-649 The Role of Methionine Residues in the Structure and Function of Parathyroid Hormone.
Zull et al., 1987, Mol. Cell. Endo. 51: 267-271 Deletion of lysine 13 alters the structure and function of parathyroid hormone.
Goldman et al., 1988, Endocrinology 123: 1468-1475 Evaluation of Novel Parathyroid Hormone analogs Using a Bovine Renal Membrane Receptor Binding Assay.
Takano et al., 1988, Acta Endo. 118:551-558 Studies of structure-function relationship of human parathyroid hormone using rat and human renal cortical cells in culture.
Zull et al., 1990, J. Biol. Chem. 265: 5671-5676 Effect of Methionine Oxidation and Deletion of Amino-terminal Residues on the Conformation of the Parathyroid Hormone.
Chorev et al., 1990, Biochemistry 29: 1580-1586 Modifications of Position 12 in Parathyroid Hormone and Parathyroid Hormone Related Protein: Toward the Design of Highly Potent Antagonists.
Gardella et al., 1990, J. Biol. Chem. 265: 15854-15859 Expression of human parathyroid hormone-(1-84) in Escherichia coli as a factor X-cleavable fusion protein.
Gardella et al., 1992, Endo. 132 (5): 2024-2030 Analysis of parathyroid hormone's principle receptor-binding region by site-directed mutagenesis and analog design.
Gardella et al., 1991, J. Biol. Chem. 266: 13141-13146 Mutational Analysis of the Receptor-activating Region of Human Parathyroid Hormone.
Sung et al., 1991, J. Biol. Chem. 266:2831-2835 Specific Degenerate Condons Enhanced Selective Expression of Human Parathyroid Hormone in Escherichia coli.
Jouishomme et al., 1992, Endocrinology 130:53-60 The Protein Kinase-C Activation Domain of the Parathyroid Hormone.
Fujimori et al., 1992, Endocrinology 130: 29-36 Structure-function relationship of parathyroid hormone: Activation of phosopholipase-C, protein kinase-A and -C in osteosarcoma cells.
Kareem et al., 1992, Analyt. Biochem. 204:26-33 A Method for the Evaluation of the Efficiency of Signal Sequences for Secretion and Correct N-terminal Processing of Human Parathyroid Hormone Produced in Escherichia coli.
Olstad et al., 1992, Eur. J. Biochem. 205: 311-319 Isolation and characterization of two biologically active O-glycosylated forms of human parathyroid hormone produced in Sccharomyces cerevisiae.
Ljunggren et al., 1992, Bioscience Reports 12 (3): 207-214 Effects of parathyroid hormone on cyclic AMP-fromation and cytoplasmic free Ca2 in the osteosarcoma cell line UMR 106-01.
Glover, 1984, Gene Cloning 110-127 The mechanics of DNA manipulation.
Cohen et al., 1991, J. Biol. Chem. 266 (3): 1997-2004 Analogues of parathyroid hormone modified at positions 3 and 6.
Pun, 1989, J. Biochem 106:1090-1093 The importance of parathyroid hormone in inhibition of collagen synthesis and mitogenesis of osteoblastic cell.
Linkhart et al., 1991, Endo. 128 (3): 1511-1518 Differential regulation of insulin-like growth factor-I (IGF-I) and IGF-II release from cultured neonatal mouse calvaria by parathyroid hormone, transforming growth factor-b, and 1,25-Dihydroxyvitamin D3.
Wronski et al., 1993, Endo. 132 (2): 823-831 Parathyroid hormones is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats.
Abou-Samra et al., 1993, Endo. 132 (2): 801-805 Parathyroid hormone (PTH) stimulates adrenocorticotropin release in AtT-20 cells stably expressing a common receptor for PTH and PTH-related peptide.
Tada et al., 1990, Bone 11: 163 169 Restoration of axial and appendicular bone volumes by h-PTH (1-34) in parathyroidectomized and osteopenic rats.
Ching Liu et al., 1990, J. Bone & Mineral Res. 5 (9): 973-982 Human parathyroid hormone (1-34) prevents bone loss and augments bone fromation in sexually mature ovariectomized rats.
Scott et al., 1992, Mol. Endo. 8 (12): 2153-2160 Parathyroid hormone induces transcription of collagenase in rat osteoblastic cells by a mechanism using cyclic adenosine 3'5'-monophosphate and requiring protein synthesis.
Linkhart et al., 1991, Endo. 125 (3): 1484-1491 Parathyroid hormone stimulates release of insulin()like growth factor-I (IGIF) and IGF-II from neonatal mouse calvaria in organ culture*.

Affiliated with

Also associated with

Rating

Compounds with PTH activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds with PTH activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds with PTH activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-686293